Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Observed Findings

• IgG anti-herpesviral reactivities (HHV-1-7) showed no significant overall differences between ME/CFS patients and healthy controls
• ME/CFS samples showed different reactivity patterns with whole HHV-1 virus antigens compared to controls
• ME/CFS samples displayed different responses to EBV-specific antigens (EBNA6 and EA) versus control samples
• Novel epitope information was identified through analysis of herpesviral peptides and human sera reactivity
• The high-precision suspension multiplex immunoassay format enabled detection of minor relative differences not visible in standard approaches

Inferred Conclusions

• ME/CFS patients maintain similar overall IgG antibody levels to herpesviruses (HHV-1-7) as healthy blood donors, suggesting comparable lifetime herpesvirus exposure
• The immune system of some ME/CFS patients interacts with ubiquitous herpesviruses in a subtly different manner than healthy controls, though the clinical significance is unclear
• Detailed serological profiling may reveal immune differences in ME/CFS that are not apparent in gross antibody level comparisons
• Herpesviruses alone are unlikely to be the primary differentiating factor between ME/CFS and healthy controls at the antibody level

Remaining Questions